At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.
Management of patients with ovarian cancer in the COVID-19 era / Bogani, G.; Casarin, J.; Pinelli, C.; Di Donato, V.; Bosio, S.; Ruisi, S.; Brusadelli, C.; Guerrisi, R.; Sarpietro, G.; Ditto, A.; Ghezzi, F.; Raspagliesi, F.. - In: JOURNAL OF SURGICAL ONCOLOGY. - ISSN 0022-4790. - 122:2(2020), pp. 122-123. [10.1002/jso.26057]
Management of patients with ovarian cancer in the COVID-19 era
Bogani G.;Di Donato V.;
2020
Abstract
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.| File | Dimensione | Formato | |
|---|---|---|---|
|
Bogani_Ovarian-cancer_2020.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
300.48 kB
Formato
Adobe PDF
|
300.48 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
